Sankarasubramanian Rajaram
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 26, 2024
Modelling the Relative Vaccine Efficacy of ARCT-154, a Self-Amplifying mRNA COVID-19 Vaccine, versus BNT162b2 Using Immunogenicity Data.Van Hung Nguyen, Pascal Crépey, Jean Marie Pivette
|Dec 23, 2023
Correction: Rockman et al. Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness. Vaccines 2023, 11, 52.Steven Rockman, Karen Laurie, Chi Ong
|Jan 21, 2023
Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness.Steven Rockman, Karen Laurie, Chi Ong
|Mar 25, 2021
Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany.Rui Cai, Laetitia Gerlier, Martin Eichner
|Aug 01, 2020
Retrospective Assessment of the Antigenic Similarity of Egg-Propagated and Cell Culture-Propagated Reference Influenza Viruses as Compared with Circulating Viruses across Influenza Seasons 2002-2003 to 2017-2018.Sankarasubramanian Rajaram, Pirada Suphaphiphat, Josephine van Boxmeer
|Dec 16, 2017
Impact of increased influenza vaccination in 2-3-year-old children on disease burden within the general population: A Bayesian model-based approach.Sankarasubramanian Rajaram, Witold Wiecek, Richard Lawson
Pageof 1
